Evan B. Cunningham

Nov 12, 2024 | mdpi.com | Alison D. Marshall |Anna Conway |Evan B. Cunningham |Heather Valerio

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Feb 14, 2024 | thelancet.com | Graham Cooke |Barnaby Flower |Evan B. Cunningham |Alison D. Marshall

Globally, more than 300 million individuals are living with hepatitis B or C. Deaths and disability caused by the long-term complications of these chronic infections—cirrhosis, liver failure, and hepatocellular carcinoma—represent a major public health challenge, comparable in scale to other major communicable diseases such as tuberculosis and malaria. In 2016, WHO set ambitious goals to eliminate viral hepatitis as a public health threat by 2030.

Feb 14, 2024 | thelancet.com | Graham Cooke |Barnaby Flower |Evan B. Cunningham |UNSW Sydney

1. Cooke GS Andrieux-Meyer I Applegate TL et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019; 4: 135-1842. Ward JW Wiktor SZ Cooke GS Launch of the Coalition for Global Hepatitis Elimination: a recommendation of the Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020; 5: 8-103.